World's Best Scientists 2026 revealed!
Carl-Henrik Heldin

Carl-Henrik Heldin

Award Badge
Best Scientists
2025
Award Badge
Molecular Biology
Sweden
2026

D-Index & Metrics

Best Scientists

D-Index
177
Citations
115642
World Ranking
677
National Ranking
10

Molecular Biology

D-Index
178
Citations
109296
World Ranking
38
National Ranking
1

Carl-Henrik Heldin publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Carl-Henrik Heldin sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 610 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Carl-Henrik Heldin D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Carl-Henrik Heldin sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 178 D-Index — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Molecular Biology in Sweden Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Molecular Biology in Sweden Leader Award
  • 2024 - Research.com Genetics and Molecular Biology in Sweden Leader Award
  • 2023 - Research.com Molecular Biology in Sweden Leader Award
  • 2022 - Research.com Genetics and Molecular Biology in Sweden Leader Award
  • 2016 - Fellow of the American Academy of Arts and Sciences
  • 1999 - Member of Academia Europaea
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)

Overview

Carl-Henrik Heldin is affiliated with Uppsala University in Sweden and has contributed extensively to the fields of biochemistry, genetics, molecular biology, and medicine with a focus on molecular biology and oncology. Their research spans various subfields including cancer research, cell biology, and biotechnology.

The main topics of work associated with their research include:

  • TGF-β signaling in diseases
  • Cancer Cells and Metastasis
  • Cancer-related Molecular Pathways
  • Ubiquitin and proteasome pathways
  • Cancer-related molecular mechanisms research
  • Proteoglycans and glycosaminoglycans research
  • Cancer Research and Treatments

Frequent collaborators in their research include:

  • Aristidis Moustakas (16 collaborations)
  • Kohei Miyazono (10 collaborations)
  • Laia Caja (7 collaborations)
  • Peter ten Dijke (6 collaborations)
  • Sannie Culbertson (6 collaborations)

The scientist has published in several notable venues, with the most frequent being:

  • Trends in Biochemical Sciences (6 publications)
  • Cancers (4 publications)
  • Cancer Science (3 publications)
  • Oncogene (2 publications)
  • International Journal of Molecular Sciences (2 publications)

Selected recent papers include:

  • Platelet-Specific PDGFB Ablation Impairs Tumor Vessel Integrity and Promotes Metastasis, 2020, Cancer Research
  • Bone morphogenetic protein receptors: Structure, function and targeting by selective small molecule kinase inhibitors, 2020, Bone
  • TGFβ and EGF signaling orchestrates the AP-1- and p63 transcriptional regulation of breast cancer invasiveness, 2020, Oncogene
  • Extracellular Vesicles and Transforming Growth Factor β Signaling in Cancer, 2022, Frontiers in Cell and Developmental Biology
  • The noncoding MIR100HG RNA enhances the autocrine function of transforming growth factor β signaling, 2021, Oncogene

The scientist has been recognized with the following awards and honors:

  • Fellow of the American Academy of Arts and Sciences, 2016
  • Member of Academia Europaea, 1999
  • Member of the European Molecular Biology Organization (EMBO)

Best Publications

  • TGF-beta signalling from cell membrane to nucleus through SMAD proteins

    Carl-Henrik Heldin;Kohei Miyazono;Peter ten Dijke

  • Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor

    Carl-Henrik Heldin;Bengt Westermark

  • Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling

    Atsuhito Nakao;Mozhgan Afrakhte;Anita Morn;Takuya Nakayama

  • Dimerization of cell surface receptors in signal transduction

    Carl-Henrik Heldin

  • Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus.

    Michael D. Waterfield;Geoffrey T. Scrace;Nigel Whittle;Paul Stroobant

  • Non-Smad TGF-β signals

    Aristidis Moustakas;Carl-Henrik Heldin

  • Smad regulation in TGF-beta signal transduction.

    Aristidis Moustakas;Serhiy Souchelnytskyi;Carl-Henrik Heldin

  • TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.

    Atsuhito Nakao;Takeshi Imamura;Takeshi Imamura;Serhiy Souchelnytskyi;Masahiro Kawabata

  • Specificity, diversity, and regulation in TGF-β superfamily signaling

    Ester Piek;Carl-Henrik Heldin;Peter Ten Dijke

  • The regulation of TGFβ signal transduction

    Aristidis Moustakas;Carl-Henrik Heldin

  • Growth factors: Mechanism of action and relation to oncogenes

    Carl-Henrik Heldin;Bengt Westermark

  • Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progression

    Aristidis Moustakas;Carl Henrik Heldin

  • SIGNAL TRANSDUCTION VIA PLATELET-DERIVED GROWTH FACTOR RECEPTORS

    Carl-Henrik Heldin;Arne Östman;Lars Rönnstrand

  • Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor.

    P Franzén;P ten Dijke;H Ichijo;H Yamashita

  • cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines

    Christer Betsholtz;Ann Johnsson;Carl-Henrik Heldin;Bengt Westermark

  • Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization.

    K Miyazono;U Hellman;C Wernstedt;C H Heldin

  • Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor.

    Fuyuki Ishikawa;Kohei Miyazono;Kohei Miyazono;Ulf Hellman;Hannes Drexler

  • PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor.

    Xuri Li;Annica Pontén;Karin Aase;Linda Karlsson

  • Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4.

    P. ten Dijke;H. Yamashita;T.K. Sampath;A.H. Reddi

  • Platelet-derived Growth Factor and Its Receptors in Human Glioma Tissue: Expression of Messenger RNA and Protein Suggests the Presence of Autocrine and Paracrine Loops

    Monica Hermanson;Keiko Funa;Magdalena Hartman;Lena Claesson-Welsh

Frequent Co-Authors

Bengt Westermark
Bengt Westermark Uppsala University
Kohei Miyazono
Kohei Miyazono University of Tokyo
Aristidis Moustakas
Aristidis Moustakas Uppsala University
Lars Rönnstrand
Lars Rönnstrand Lund University
Arne Östman
Arne Östman Karolinska Institute
Lena Claesson-Welsh
Lena Claesson-Welsh Uppsala University
Ulf Hellman
Ulf Hellman Ludwig Cancer Research
Christer Wernstedt
Christer Wernstedt Ludwig Cancer Research
Peter ten Dijke
Peter ten Dijke Leiden University Medical Center
Christer Betsholtz
Christer Betsholtz Uppsala University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a degree in Molecular Biology can open doors to diverse fields, including healthcare and biotechnology. Many students with a science background consider complementary online degrees that enhance job opportunities and salary potential.

If you’re interested in transitioning into nursing, consider online accelerated BSN programs for non nurses. These programs are designed for those with a non-nursing bachelor’s degree, letting you earn your nursing credentials quickly.

Registered nurses looking to advance their qualifications can benefit from rn to bsn 6 months programs, which offer a fast-track way to gain a Bachelor of Science in Nursing.

For those considering a more advanced practice role, it’s helpful to learn how to become a np. Nurse practitioners are in high demand and can specialize in fields such as psychiatric care.

Salary prospects also vary by area of specialization and location. To get an idea of earning potential, review pmhnp salary by state.

Best Scientists Citing Carl-Henrik Heldin

Trending Scientists

Recently Published Articles